| 2D Structure | |
| CID | 5147 |
| IUPAC Name | 2-hydroxybenzamide |
| InChI | InChI=1S/C7H7NO2/c8-7(10)5-3-1-2-4-6(5)9/h1-4,9H,(H2,8,10) |
| InChI Key | SKZKKFZAGNVIMN-UHFFFAOYSA-N |
| Canonical SMILES | None |
| Isomeric SMILES | None |
| Molecular Formula | C7H7NO2 |
| Molecular Weight | 137.14 |
| synonyms | ['salicylamide', '2-Hydroxybenzamide', '65-45-2', 'o-Hydroxybenzamide', '2-Carbamoylphenol', 'Benzamide, 2-hydroxy-', 'Salicylic acid amide', '2-Carboxamidophenol', 'Algiamida', 'Panithal', 'Oramid', 'Urtosal', 'Acket', 'Amidosal', 'Dolomide', 'Dropsprin', 'Liquiprin', 'Morsarinas', 'Raspberin', 'Saliamid', 'Saliamin', 'Salizell', 'Serramida', 'Algamon', 'Allevin', 'Anamid', 'Novecyl', 'Salicim', 'Salipur', 'Salrin', 'Salymid', 'Afko-Sal', 'Amid-Sal', 'Salicilamida', 'Benzamide, o-hydroxy-', 'Salicilamide', 'Salicylamidum', 'Cidal', 'Samid', 'H.P. 34', 'SR 4326', 'Benzoic acid, 2-hydroxy-, amide', 'NSC-3115', 'EM8BM710ZC', 'DTXSID3021726', 'DTXCID501726', 'CHEBI:32114', 'RefChem:6211', 'N02BA05', '200-609-3', 'Benesal', 'Salamid', 'Flarpirina', 'Andasol', 'Eggosalil', 'Salamide', 'MFCD00007978', '2-Hydroxy-benzamide', 'Amid kyseliny salicylove', 'OHB', 'NSC 3115', 'CHEMBL27577', 'MLS000069486', 'NCGC00091414-02', 'SMR000046394', 'Salicylamide 100 microg/mL in Acetonitrile', 'Salizell (VAN)', 'Benesal (VAN)', 'Salicilamide [DCIT]', 'Salicilamide [Italian]', 'Salicylamidum [INN-Latin]', 'CAS-65-45-2', 'Salicilamida [INN-Spanish]', 'CCRIS 6045', 'HSDB 227', 'Amid kyseliny salicylove [Czech]', 'EINECS 200-609-3', 'UNII-EM8BM710ZC', 'BRN 0742439', 'Salicylamid', 'AI3-03454', 'hydroxy benzamide', 'dihydroxybenzalamine', 'Salicylamide [USP:INN:BAN:JAN]', 'Salicylamide, 99%', 'Spectrum_000946', 'Salicylamide (Standard)', 'Opera_ID_1684', 'Spectrum2_001312', 'Spectrum3_000564', 'Spectrum4_000499', 'Spectrum5_001032', 'SALICYLAMIDE [MI]', 'WLN: ZVR BQ', 'SALICYLAMIDE [INN]', 'SALICYLAMIDE [JAN]', 'EC 200-609-3', 'SALICYLAMIDE [HSDB]', 'NCIOpen2_001127', 'SALICYLAMIDE [VANDF]', 'Oprea1_069894', 'SCHEMBL21646', 'BSPBio_001948', 'KBioGR_001017', 'KBioSS_001426', 'SALICYLAMIDE [MART.]', '4-10-00-00169 (Beilstein Handbook Reference)', 'Deferasirox Benzamide Impurity', 'DivK1c_000858', 'SALICYLAMIDE [USP-RS]', 'SALICYLAMIDE [WHO-DD]', 'SCHEMBL162829', 'SCHEMBL875217', 'SPECTRUM1500532', 'Salicylamide (JAN/USP/INN)', 'SPBio_001403', 'benzenecarboxamide, 2-hydroxy-', 'orb1311036', 'SCHEMBL1975862', 'SCHEMBL4116744', 'SCHEMBL10915695', 'SCHEMBL11516367', 'SCHEMBL29384763', 'HMS502K20', 'HY-B0811R', 'KBio1_000858', 'KBio2_001426', 'KBio2_003994', 'KBio2_006562', 'KBio3_001448', 'NSC3115', 'NINDS_000858', 'HMS1920P14', 'HMS2092G15', 'HMS2232E07', 'HMS5085G18', 'Pharmakon1600-01500532', 'component of Tolagesic (Salt/Mix)', 'HY-B0811', 'MSK11195', 'SALICYLAMIDE [USP MONOGRAPH]', 'Tox21_111129', 'Tox21_201944', 'Tox21_302801', 'BBL016007', 'BDBM50056900', 'CCG-39250', 'EBC-03127', 'NSC757318', 's6404', 'SBB058584', 'STK301812', 'AKOS000120983', 'Tox21_111129_1', 'CS-7630', 'DB08797', 'FS27782', 'NSC-757318', 'IDI1_000858', 'NCGC00091414-01', 'NCGC00091414-03', 'NCGC00091414-04', 'NCGC00091414-05', 'NCGC00091414-07', 'NCGC00256376-01', 'NCGC00259493-01', '287492-04-0', 'DS-16216', 'Salicylamide, puriss., >=99.0% (T)', 'SY009157', 'SBI-0051509.P003', 'DB-269424', 'EU-0000058', 'NS00006293', 'S0006', 'ST45061688', 'EN300-18542', 'D01811', 'F85552', 'AB00052089_12', 'AH-034/32461056', 'F091532', 'SR-01000721923', 'BENZOIC ACID,2-HYDROXY,AMIDE SALICYLAMIDE', 'Q2496906', 'SR-01000721923-2', 'BRD-K81130846-001-02-6', 'BRD-K81130846-001-12-5', 'BRD-K81130846-001-17-4', 'Z68590124', 'F0451-0020', '2,4-CYCLOHEXADIEN-1-ONE, 6-(AMINOHYDROXYMETHYLENE)-', 'Salicylamide, United States Pharmacopeia (USP) Reference Standard', 'InChI=1/C7H7NO2/c8-7(10)5-3-1-2-4-6(5)9/h1-4,9H,(H2,8,10', 'Salicylamide, Pharmaceutical Secondary Standard; Certified Reference Material'] |
From Pubchem